Please assess the completion status of the following clinical trial:

Trial Title: Patient-centered Development of the Cancer Support Community's Open to Options ®Chatbot Program

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a cancer diagnosis~* Able to speak and read English, and willing to electronically consent~* Appointment with a Rogel Cancer Center cancer clinician within the next 3 weeks~* Patient must have a way to access the internet (includes mobile phone)~Exclusion Criteria:~* Age \<18 years~* Inability to speak or read English~* Inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pre-Chatbot survey arm (Type: ACTIVE_COMPARATOR): Participants will take the self-appraisal survey prior to interacting with the O2O program via the online Chatbot.
- Post-Chatbot survey arm (Type: EXPERIMENTAL): Participants will take the self-appraisal survey after interacting with the O2O program via the online Chatbot. (This arm will also answer additional questions regarding participants' satisfaction with the O2O Chatbot.)

Based on this trial design, predict the completion outcome and termination type (if applicable).